Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)

• Status: Completed
• Trial end date: 2019-09-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the use of spirometry in identifying Diagnostic Error in COPD and Asthma patients.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Illinois at Chicago
• Collaborator: Agency for Healthcare Research and Quality (AHRQ)
• Treatments: Albuterol

Criteria

Inclusion Criteria:

• 1.Age >40 years of age

• 2. Use of a maintenance respiratory medication and one of the following in the past year:

• 3. Diagnosis of asthma and/or COPD

• 4. No spirometry test performed in the past 3 years

• 5. Past or current smoker or is exposed to tobacco

Exclusion Criteria:

• Unable to perform adequate spirometry

• Non-English speaking

• Pregnancy

• Plans to move from the Chicago Area within the next year

• Seen by pulmonary specialist in the past 3 years

• Any terminal illness with a life expectancy of <6 months

• Life threatening (e.g. intensive care admission and/or use of mechanical ventilation) respiratory failure event in the past year.